Affordable hematology testing is the need of the hour

-

A blood test today holds the key to every treatment outcome. In the wake of the growing number of blood disorders, hematology testing has become critical. In order to reach out to the 70% Indians in need of blood testing, manufacturers need to provide solutions that are affordable and give accurate results.


The increasing prevalence of blood diseases and disorders, pose a global health challenge and are associated with high morbidity and mortality. From the patients’ perspective, this has led to increasing awareness of diseases and shift from sickness to wellness.

 Look at it from the perspective of the IVD Industry; hematology has grown to be recognized as a distinct steam of laboratory medicine. Technological advancements, increasing adoption of automated hematology instruments, integration of basic flow-cytometry techniques, usage of microfluidics technology, introduction of digital imaging for cell morphology, rising demand for high-throughput hematology analyzers & development of high-sensitivity point-of-care (POC) hematology testing are all factors contributing to the growth of this segment. 

 Asia-Pacific is estimated to be the fastest growing market due to the rapidly developing healthcare infrastructure and increased funding. Speaking of India, the hematology market has yielded close to INR 1300 crores for FY 2018-19. 

 Technological advancements in this segment has led to reporting of advanced parameters even by the most basic automated analyzers. These parameters provide detailed clinical insights for the differential diagnosis of various blood disorders. Particularly relevant in India, these parameters help in detection of anemia and other hemoglobinopathies. Ironically, there is still a large section of the society, which is devoid of basic laboratory investigations.  

 To add to that, factors such as high cost of instruments, regulatory constraints and strong competition, act as roadblocks.

 Limited access to quality medical infrastructure, including skilled manpower and technologies has been the pain points of over 70% of Indians who live in smaller towns and rural areas. The need of the hour is for Indian manufacturers to cater to this 70%. This can be done by providing latest technological advancements at affordable rates. 

 Transasia Bio-Medicals Ltd., India’s No. 1 IVD Company has been providing Make in India products with an aim to provide affordable diagnostic solutions. Just recently, Transasia introduced its latest range of three and five part fully automated hematology analyzers, which have been developed at Erba Europe, the global R&D facility of Transasia. These instruments, are set to provide affordable diagnosis to cater to the masses.

Authored by:







Dr. Avi Nahar, 
Business Unit Head - Hematology, 

Comments

Post a Comment

Popular posts from this blog

HbA1c: An Important Biomarker in diagnosis and prognosis of diabetes patients

-
Image
  One of the main purposes of laboratory tests is to aid medical reasoning after obtaining the clinical history and performing the physical examination by the laboratory team. To this end, all test execution phases, especially the pre-analytical phase, must be conducted following the technical rigor necessary to ensure patient safety and accurate results, so that the conduction of the patient's prognosis is more assertive. The measurement of HbA1c, when measured in whole blood, by immunoturbidimetric assay, in biochemical equipment from the XL family, such as the XL 200 equipment, plays an important role in the diagnosis of Diabetes. Diabetes is a global endemic with rapidly increasing prevalence in both developing and developed countries. The American Diabetes Association has recommended glycated hemoglobin (HbA1c) as a possible substitute to fasting blood glucose for diagnosis of diabetes. HbA1c is an important indicator of long-term glycemic control with the ability to refle...
Read more

Amorphous urates: What they are, diagnosis and treatment

-
Image
  Amorphous urates are a type of crystal that varies in colour from yellow to black, identified in the urine test. This can arise due to the cooling of the sample during packaging for transport or due to the acidic pH of the urine, with the values ​​being observed equal to or less than 5.5. Examination of abnormal urine elements and sediment (EAS) can be performed manually or automatically. Automated urinalysis devices available on the market are accurate, reproducible, faster and much less labor intensive (walk-away instruments) than standard manual microscopy. It can be run directly at patient-side without any further sample manipulation (e.g. refrigeration, centrifugation etc.). It has the potential to markedly reduce human factor from interpretation by consistently applying the same algorithm to the analysis of every sample. The Erba Laura XL is an automated device that performs three phases that make up the EAS, from the physical and chemical part to the sedimentoscopy/microsc...
Read more

Biochemical liver markers

-
Image
  Liver function tests (also known as a liver panel) are blood tests that measure different enzymes, proteins, and other substances made by the liver. These tests check the overall health of your liver. Transasia offers a wide menu of test parameters in convenient pack sizes in powder and liquid stable formats as well as system packs for Erba range of fully automated analyzers. The use of serum biochemical tests plays an important role in the diagnosis and treatment of liver diseases. However, an isolated test provides limited information, which must be evaluated in the context of the patient's history and clinical condition. Biochemical liver tests consist of markers of hepatocellular injury (aminotransferases and alkaline phosphatase), liver metabolism tests (bilirubins), and liver synthetic function tests (serum albumin and prothrombin time [PT]).   Hepatic injury markers The liver contains a high concentration of enzymes, some of which are present in serum i...
Read more